Abstract 228: Activation of the Free Fatty Acid Receptor GPR120 Prevents Fibrosis in NIH3T3 Cells and Primary Cardiac Fibroblasts

2012 ◽  
Vol 111 (suppl_1) ◽  
Author(s):  
Qingwen Qian ◽  
Tim D O'Connell

Fibrosis significantly contributes to contractile dysfunction and pathologic ventricular remodeling in heart failure. Recently, we showed for the first time that ω3-polyunsaturated fatty acids (ω-PUFAs) prevent fibrosis and cardiac dysfunction in pressure-overload induced heart failure through inhibition of collagen expression, fibroblast proliferation, and fibroblast-to-myofibroblast transformation. In cultured cardiac fibroblasts, we found that ω3-PUFAs induced eNOS activity to prevent TGFβ1-Smad2/3 pro-fibrotic signaling. Mechanistically, ω3-PUFAs are thought to regulate ion channels or to incorporate into the membrane and alter the properties of lipid-rafts, but how a fatty acid might activate eNOS is unknown. Recently, GPR40 and GPR120 were identified as receptors for long-chain fatty acids (FFARs). Here, we examined GPR120 regulation of cardiac fibrosis. Among the FFARs, GPR40, 41, 43, 84, and 120, GPR120 mRNA was expressed at highest level in whole heart. Furthermore, we detected GPR120 expression in isolated cardiac myocytes and fibroblasts, as well as NIH3T3 mouse embryonic fibroblasts. To determine if activation of GPR120 was sufficient to prevent fibrosis, we tested the ability of the GPR120 agonist GW9508 to prevent TGFβ1-induced fibrosis in both NIH3T3 cells and primary cultures of cardiac fibroblasts. In both NIH3T3 cells and primary cardiac fibroblasts, TGFβ1 (1 ng/ml) induced a pro-fibrotic response indicated by increased fibroblast proliferation, α-smooth muscle actin expression, and collagen I expression. In both cell types, pre-treatment with GW9508 significantly inhibited TGFβ1-induced proliferation (63% in NIH 3T3 cells and 52% in cardiac fibroblasts, respectively), α-smooth muscle actin expression (78% in NIH 3T3 cells, 90% in cardiac fibroblasts), and collagen I expression. In summary, our results demonstrate for the first time, that GPR120 signaling in the heart prevents fibrosis.

Heart ◽  
2014 ◽  
Vol 100 (Suppl 1) ◽  
pp. A6.3-A7 ◽  
Author(s):  
C Kane ◽  
J Cartledge ◽  
P Dias ◽  
P Camelliti ◽  
M Yacoub ◽  
...  

2014 ◽  
Vol 106 (2) ◽  
pp. 759a
Author(s):  
Priyanthi Dias ◽  
Manoraj Navaratnarajah ◽  
Samha Alayoubi ◽  
Christopher Kane ◽  
Leanne E. Felkin ◽  
...  

1992 ◽  
Vol 28 (4) ◽  
pp. 293-296 ◽  
Author(s):  
Daniele Brouty-Boye ◽  
Despina Kolonias ◽  
Niramol Savaraj ◽  
Theodore J. Lampidis

2010 ◽  
Vol 37 (8) ◽  
pp. 1680-1687 ◽  
Author(s):  
THONG HUA-HUY ◽  
KIET PHONG TIEV ◽  
CHRISTIANE CHÉREAU ◽  
SY DUONG-QUY ◽  
JEAN CABANE ◽  
...  

Objective.Lung inflammation is present in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD), but the mechanisms linking inflammatory and fibrotic processes in ILD are unknown. Our aim was to investigate whether alveolar inflammation, reflected by increased alveolar concentration of exhaled nitric oxide (CANO), is related to the ability of serum from patients with SSc to induce pulmonary fibroblast proliferation (PFP) and myofibroblast conversion.Methods.CANO was measured in all subjects (37 patients with SSc and 10 healthy controls) whose sera were used to stimulate PFP (assessed by BrdU labeling index) and myofibroblast conversion (detected by α-smooth muscle actin expression). The PFP index in patients with SSc was compared to control values, and between patients with SSc who had elevated (> 4.3 ppb) and normal (≤ 4.3 ppb) CANO values.Results.Both CANO and the PFP index were significantly greater in patients with SSc compared to controls. In patients with SSc, the PFP index was directly related to CANO levels (r = 0.48; p = 0.002). The median PFP index was significantly higher in patients with SSc who had elevated CANO (> 4.3 ppb; n = 25, median 1.1, range 0.98–1.23) than in patients with SSc who had normal CANO (≤ 4.3 ppb; n = 12, median 0.93, range 0.82–1.08; p = 0.01). Similarly, myofibroblast conversion induced by SSc serum was significantly greater in patients with CANO > 4.3 ppb than in patients whose CANO was ≤ 4.3 ppb (p < 0.001) and controls (p < 0.001).Conclusion.Alveolar inflammation reflected by increased nitric oxide production was related to serum-induced PFP and myofibroblast conversion, linking the active alveolitis process to cell proliferation and lung fibrosis in patients with SSc.


Sign in / Sign up

Export Citation Format

Share Document